Cutting-edge research into developing personalised mRNA vaccines for cancer patients will be accelerated following the UK's successful Covid-jab rollout.BioNTech, the German firm that co-produced a Covid vaccine with Pfizer, will partner with the government to deliver 10,000 personalised therapies to patients in the UK by 2030.
#effectively #partnership #successfully #covid-vaccine #health-secretary #immune-system #early-access #chemotherapy #nhs-england #national-health-service
[
add
]
[
|
|
...
]